Juan; Veronica
Patent Applications and Registrations
Patent applications and USPTO patent grants for Juan; Veronica.The latest application filed is for "anti-pd-1/lag3/tigit trispecific antibodies and anti-pd-1/lag3 bicpecific antibodies".
- Juan; Veronica - Redwood City CA
- JUAN; Veronica - Palo Alto CA
| Patent | Date |
|---|---|
| Anti-pd-1/lag3/tigit Trispecific Antibodies And Anti-pd-1/lag3 Bicpecific Antibodies App 20220251194 - Fayadat-Dilman; Laurence ; et al. | 2022-08-11 |
| Antibodies Specific For Immunoglobulin-like Transcript 3 (ilt3) And Uses Thereof App 20220033497 - Meehl; Michael A. ; et al. | 2022-02-03 |
| Antibodies Specific For Immunoglobulin-like Transcript 3 (ilt3) And Uses Thereof App 20220025043 - Meehl; Michael A. ; et al. | 2022-01-27 |
| Antibodies Specific For Immunoglobulin-like Transcript 3 (ilt3) And Uses Thereof App 20220025042 - Meehl; Michael A. ; et al. | 2022-01-27 |
| Antibodies Specific For Immunoglobulin-like Transcript 3 (ilt3) And Uses Thereof App 20220010010 - Meehl; Michael A. ; et al. | 2022-01-13 |
| Antibodies Specific For Immunoglobulin-like Transcript 3 (ilt3) And Uses Thereof App 20220010011 - Meehl; Michael A. ; et al. | 2022-01-13 |
| Anti-pd-1/lag3 Bispecific Antibodies App 20210371530 - FAYADAT-DILMAN; Laurence ; et al. | 2021-12-02 |
| Anti-pd-1/lag3 Bispecific Antibodies App 20210363256 - FAYADAT-DILMAN; Laurence ; et al. | 2021-11-25 |
| Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof Grant 11,111,297 - Meehl , et al. September 7, 2 | 2021-09-07 |
| Anti-PD-1/LAG3 bispecific antibodies Grant 11,072,658 - Fayadat-Dilman , et al. July 27, 2 | 2021-07-27 |
| Anti-TNF.alpha. binding compounds and uses thereof Grant 10,947,305 - DuBridge , et al. March 16, 2 | 2021-03-16 |
| Anti-pd-1 Antibodies App 20210032342 - FAYADAT-DILMAN; Laurence ; et al. | 2021-02-04 |
| Anti-tigit Antibodies App 20210017276 - Williams; Sybil M.G. ; et al. | 2021-01-21 |
| Anti-B7H3 binding compounds and uses thereof Grant 10,865,245 - DuBridge , et al. December 15, 2 | 2020-12-15 |
| Anti-TIGIT antibodies Grant 10,766,957 - Williams , et al. Sep | 2020-09-08 |
| Anti-cd27 Antibodies App 20200131272 - Beebe; Amy M. ; et al. | 2020-04-30 |
| Anti-CD27 antibodies Grant 10,556,957 - Beebe , et al. Feb | 2020-02-11 |
| Novel Anti-b7h3 Binding Compounds And Uses Thereof App 20190338030 - DuBridge; Robert ; et al. | 2019-11-07 |
| Anti-cd27 Antibodies App 20190300618 - Beebe; Amy M. ; et al. | 2019-10-03 |
| Anti-pd-1/lag3 Bispecific Antibodies App 20190233518 - Fayadat-Dilman; Laurence ; et al. | 2019-08-01 |
| Antibodies Specific For Immunoglobulin-like Transcript 3 (ilt3) And Uses Thereof App 20190153093 - MEEHL; MICHAEL A. ; et al. | 2019-05-23 |
| Anti-tigit Antibodies App 20180371083 - Williams; Sybil M.G. ; et al. | 2018-12-27 |
| Fc variants with improved complement activation Grant 10,150,814 - Hinton , et al. Dec | 2018-12-11 |
| Anti-B7H3 binding compounds and uses thereof Grant 9,963,509 - DuBridge , et al. May 8, 2 | 2018-05-08 |
| Anti-cd27 Antibodies App 20180086841 - Beebe; Amy M. ; et al. | 2018-03-29 |
| NOVEL ANTI-TNFalpha BINDING COMPOUNDS AND USES THEREOF App 20180051076 - DuBridge; Robert ; et al. | 2018-02-22 |
| Novel Anti-b7h3 Binding Compounds And Uses Thereof App 20170362322 - DuBridge; Robert ; et al. | 2017-12-21 |
| CTLA4 proteins and their uses Grant 9,587,007 - Akamatsu , et al. March 7, 2 | 2017-03-07 |
| Fc Variants With Improved Complement Activation App 20160137732 - HINTON; Paul R. ; et al. | 2016-05-19 |
| Ctla4 Proteins And Their Uses App 20150051158 - AKAMATSU; Yoshiko ; et al. | 2015-02-19 |
| CTLA4 proteins and their uses Grant 8,883,971 - Akamatsu , et al. November 11, 2 | 2014-11-11 |
| CTLA4 proteins and their uses Grant 8,642,557 - Akamatsu , et al. February 4, 2 | 2014-02-04 |
| Ctla4 Proteins And Their Uses App 20130330338 - AKAMATSU; Yoshiko ; et al. | 2013-12-12 |
| Ctla4 Proteins And Their Uses App 20110305712 - Akamatsu; Yoshiko ; et al. | 2011-12-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 